Home >> HealthCenter >> ClinicalTrial
Assessing Barriers to ADA Guideline Adherence

This study is currently recruiting participants.
Verified by Agency for Healthcare Research and Quality (AHRQ), November 2006

Sponsored by: Agency for Healthcare Research and Quality (AHRQ)
Information provided by: Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier: NCT00503464


This project involves a comprehensive assessment of barriers to diabetes guidelines adherence across 25 practices in the Crozer-Keystone primary care PBRN. A Barrier Assessment Tool (BAT) will be validated to correlate with provider and practice adherence to diabetes care guidelines. The network is part of the Crozer-Keystone Health System located in Delaware County, Pennsylvania, in the southeast quadrant of the Philadelphia metropolitan region.

Condition Diabetes
MedlinePlus related topics: Diabetes
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Retrospective/Prospective Study
Official Title: "Assessing Barriers to American Diabetes Association Guideline Adherence"
Further study details as provided by Agency for Healthcare Research and Quality (AHRQ): Detailed Description:

Study hypothesis: Questionnaire responses about perceived barriers to implementation of diabetes care recommendations, administered to primary care providers and staff, will be shown to correlate with that provider's and practice's success at implementing care guidelines.

Diabetes care in the U.S. consistently fails to meet recommended quality standards. Barriers impede the translation of evidence-based guidelines into sustainable practice. Few studies have considered multiple barriers, and there is a lack of evidence-based strategy in choosing interventions to overcome barriers. This study involves a comprehensive assessment of practice barriers to diabetes guidelines adherence across a primary care network. The BAT based upon a framework proposed by Cabana, et al (1999) will be validated to correlate with provider and practice adherence to diabetes care guidelines. A Diabetes Flow Sheet implemented in our Network to track adherence to guidelines will be assessed and correlated with measured barriers. This organizational strategy will support an evidence-based approach to quality initiative interventions. The BAT will be administered to practice team members: providers, support staff, and practice managers in our Network of 25 primary care practices. Five hypotheses are tested:

A: The BAT measures perceived barriers to adherence to diabetes guidelines, while showing adequate internal consistency and an identifiable subscale structure.

B: The BAT results inversely correlate with practice and provider adherence to ADA guidelines.

C: BAT scores will inversely correlate with use of the Diabetes Flow Sheet.

D: The BAT scores inversely correlate with clinical outcomes (glycemic and lipid control.)

E: Use of the Diabetes Flow Sheet correlates with higher provider and practice adherence to ADA guidelines.

The BAT would then provide the structure for comprehensive assessment of barriers. Study of the Crozer-Keystone PBRN is a real-world laboratory for research in the translation of evidence into diverse practices. The Network is optimally positioned to implement and study this organizational strategy.

Study Start Date: September 2006

Home   |   About Us   |   Contact Us   |   Privacy   |   Terms Of Use   |   Advertise With Us   |   Sitemap
Copyright © 2022 Responsive Health
This site is intended to provide you with health information from publicly available sources, supporting vendors and partnered sources. While We make every effort to ensure that the information on this site is accurate, We make absolutely no assumption, inference, or declaration stating the information provided should be use as a source influencing any decisions on medical, diagnosis or treatment, or advice about what providers to use. The Site is an informational resource used for educational purposes only and cannot be used as a source used to make changes to medical treatment or lifestyle decisions without first consulting with your physician.